Gyre Therapeutics, Inc.GYRENASDAQ
Loading
Gross Profit Growth Recovery in ProgressRecovering
Percentile Rank57
3Y CAGR-93.2%
5Y CAGR-74.3%
Year-over-Year Change
Year-over-year gross profit growth rate
3Y CAGR
-93.2%/yr
Annual compound
5Y CAGR
-74.3%/yr
Recent deceleration
Percentile
P57
Within normal range
vs 5Y Ago
0x
Contraction
Streak
1 yr
Consecutive growthRecovering
| Period | Value |
|---|---|
| 2025 | 9.13% |
| 2024 | -6.38% |
| 2023 | 11.61% |
| 2022 | 29466.57% |
| 2021 | -102.82% |
| 2020 | 8171.92% |
| 2019 | 99.32% |
| 2018 | -81.49% |
| 2017 | -16.47% |
| 2016 | -141.35% |